FITC-Linked Polyclonal Antibody to Cartilage Oligomeric Matrix Protein (COMP)
Référence MBS2052407-0,5mL
Conditionnement : 0.5mL
Marque : MyBiosource
Cartilage Oligomeric Matrix Protein (COMP) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2052407SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2052407 is an antibody targeting COMP. Also known as FITC-Linked Polyclonal Antibody to Cartilage Oligomeric Matrix Protein (COMP). Reactive in Mouse, Rat. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Cartilage Oligomeric Matrix Protein (COMP), Polyclonal Antibody
Full Product Name
FITC-Linked Polyclonal Antibody to Cartilage Oligomeric Matrix Protein (COMP)
Product Gene Name
anti-COMP antibody
Product Synonym Names
MED; EDM1; EPD1; PSACH; THBS5; TSP-5; Pseudoachondroplasia, Epiphyseal Dysplasia 1, Multiple; Thrombospondin 5
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Mouse, Rat
Concentration
500ug/ml (lot specific)
Matching Pairs
Unconjugated Antibody: COMP (MBS2003247)
FITC Conjugated Antibody: COMP (MBS2052407)
FITC Conjugated Antibody: COMP (MBS2052407)
Matching Pairs
FITC Conjugated Antibody: COMP (MBS2052407)
Immunogen: COMP (MBS2011707)
Immunogen: COMP (MBS2011707)
Molecular Weight
77,214 Da
OMIM
L32137 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Immunogen
COMP (Gln554~Gln753)
Conjugation
FITC
Cross Reactivity
Mouse, Rat
Unconjugated Antibody
The unconjugated antibody version of this item is also available as catalog #MBS2003247
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-COMP antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (ELISA)
Other Notes
Small volumes of anti-COMP antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for COMP. It may not necessarily be applicable to this product.
NCBI Official Full Name
cartilage oligomeric matrix protein
NCBI Official Synonym Full Names
cartilage oligomeric matrix protein
NCBI Official Symbol
COMP
NCBI Official Synonym Symbols
MED; EDM1; EPD1; TSP5; PSACH; THBS5
UniProt Protein Name
Cartilage oligomeric matrix protein
UniProt Synonym Protein Names
Thrombospondin-5; TSP5
Protein Family
Cartilage oligomeric matrix protein
UniProt Gene Name
COMP
UniProt Synonym Gene Names
COMP; TSP5
NCBI Protein Information
cartilage oligomeric matrix protein
NCBI Summary for COMP
The protein encoded by this gene is a noncollagenous extracellular matrix (ECM) protein. It consists of five identical glycoprotein subunits, each with EGF-like and calcium-binding (thrombospondin-like) domains. Oligomerization results from formation of a five-stranded coiled coil and disulfides. Binding to other ECM proteins such as collagen appears to depend on divalent cations. Contraction or expansion of a 5 aa aspartate repeat and other mutations can cause pseudochondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). [provided by RefSeq, Jul 2016]
Show more UniProt Comments for COMP
COMP: May play a role in the structural integrity of cartilage via its interaction with other extracellular matrix proteins such as the collagens and fibronectin. Can mediate the interaction of chondrocytes with the cartilage extracellular matrix through interaction with cell surface integrin receptors. Could play a role in the pathogenesis of osteoarthritis. Potent suppressor of apoptosis in both primary chondrocytes and transformed cells. Suppresses apoptosis by blocking the activation of caspase-3 and by inducing the IAP family of survival proteins (BIRC3, BIRC2, BIRC5 and XIAP). Essential for maintaining a vascular smooth muscle cells (VSMCs) contractile/differentiated phenotype under physiological and pathological stimuli. Maintains this phenotype of VSMCs by interacting with ITGA7. Defects in COMP are the cause of multiple epiphyseal dysplasia type 1 (EDM1). EDM is a generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. EDM is broadly categorized into the more severe Fairbank and the milder Ribbing types. Defects in COMP are the cause of pseudoachondroplasia (PSACH). PSAC is a dominantly inherited chondrodysplasia characterized by short stature and early-onset osteoarthrosis. PSACH is more severe than EDM1 and is recognized in early childhood. Belongs to the thrombospondin family.
Protein type: Secreted; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 19p13.11
Cellular Component: extracellular matrix; extracellular region; extracellular space
Molecular Function: calcium ion binding; collagen binding; extracellular matrix structural constituent; heparan sulfate proteoglycan binding; heparin binding; protease binding; protein binding
Biological Process: extracellular matrix organization and biogenesis; limb development; negative regulation of apoptosis; organ morphogenesis; skeletal development
Disease: Epiphyseal Dysplasia, Multiple, 1; Pseudoachondroplasia
Show more Protein type: Secreted; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 19p13.11
Cellular Component: extracellular matrix; extracellular region; extracellular space
Molecular Function: calcium ion binding; collagen binding; extracellular matrix structural constituent; heparan sulfate proteoglycan binding; heparin binding; protease binding; protein binding
Biological Process: extracellular matrix organization and biogenesis; limb development; negative regulation of apoptosis; organ morphogenesis; skeletal development
Disease: Epiphyseal Dysplasia, Multiple, 1; Pseudoachondroplasia
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-COMP antibody
| Reference Product | PubMed Publications |
|---|---|
| MATN1 antibody | >68 publications with COMP and MATN1 |
| SOX9 antibody | >65 publications with COMP and SOX9 |
| CD36 antibody | >42 publications with COMP and CD36 |
| COL2A1 antibody | >35 publications with COMP and COL2A1 |
| EGR1 antibody | >22 publications with COMP and EGR1 |
| BMP2 antibody | >14 publications with COMP and BMP2 |
| HDAC1 antibody | >6 publications with COMP and HDAC1 |
| ITGA2B antibody | >2 publications with COMP and ITGA2B |
Pathways associated with anti-COMP antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| ECM Proteoglycans Pathway antibodies | ECM Proteoglycans Pathway Diagram |
| ECM-receptor Interaction Pathway antibodies | ECM-receptor Interaction Pathway Diagram |
| ECM-receptor Interaction Pathway antibodies | ECM-receptor Interaction Pathway Diagram |
| Extracellular Matrix Organization Pathway antibodies | Extracellular Matrix Organization Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Integrin Cell Surface Interactions Pathway antibodies | Integrin Cell Surface Interactions Pathway Diagram |
| Malaria Pathway antibodies | Malaria Pathway Diagram |
| Malaria Pathway antibodies | Malaria Pathway Diagram |
Diseases associated with anti-COMP antibody
| Disease Name | Pubmed Publications |
|---|---|
| Disease Models, Animal Antibodies | >1783 publications with COMP and Disease Models, Animal |
| Inflammation Antibodies | >1194 publications with COMP and Inflammation |
| Necrosis Antibodies | >1044 publications with COMP and Necrosis |
| Nerve Degeneration Antibodies | >958 publications with COMP and Nerve Degeneration |
| Liver Diseases Antibodies | >892 publications with COMP and Liver Diseases |
| Kidney Diseases Antibodies | >709 publications with COMP and Kidney Diseases |
| Hypertension Antibodies | >671 publications with COMP and Hypertension |
| Fatty Liver Antibodies | >619 publications with COMP and Fatty Liver |
| Weight Loss Antibodies | >575 publications with COMP and Weight Loss |
| Weight Gain Antibodies | >520 publications with COMP and Weight Gain |
Organs/Tissues associated with anti-COMP antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Brain Antibodies | >22205 publications with COMP and Brain |
| Liver Antibodies | >6679 publications with COMP and Liver |
| Heart Antibodies | >4397 publications with COMP and Heart |
| Intestine Antibodies | >3278 publications with COMP and Intestine |
| Vascular Antibodies | >2846 publications with COMP and Vascular |
| Skin Antibodies | >2650 publications with COMP and Skin |
| Bone Antibodies | >2132 publications with COMP and Bone |
| Ovary Antibodies | >2000 publications with COMP and Ovary |
| Connective Tissue Antibodies | >1820 publications with COMP and Connective Tissue |
| Embryonic Tissue Antibodies | >1806 publications with COMP and Embryonic Tissue |


